Table 1.
Clinical and demographic characteristics of patients who died of COVID-19 and cancer.
| Characteristic | N | Percentage |
|---|---|---|
| Sex | ||
| Male | 11/15 | 733 |
| Female | 4/15 | 267 |
| Cancer type | ||
| Lung | 8/15 | 533 |
| Bladder | 2/15 | 2,8 |
| Colorectal | 2/15 | 139 |
| Prostate | 1/15 | 139 |
| Melanoma | 1/15 | 139 |
| Choriocarcinoma | 1/15 | 25 |
| Disease spread | ||
| Non-metastatic | 4/15 | 267 |
| Metastatic | 11/15 | 733 |
| Cancer treatment | ||
| Follow-up without treatment | 4/15 | 267 |
| Not started | 2/15 | 133 |
| Active | 6/15 | 40 |
| Symptomatic | 3/15 | 20 |
| Comorbidities | ||
| Hypertension | 10/15 | 666 |
| Chronic lung disease | 4/15 | 266 |
| Obesity | 2/15 | 133 |
| Diabetes | 1/15 | 6,6 |
| Renal failure | 1/15 | 6,6 |